Published in Circulation on December 19, 2012
PITA-HF: Feasibility, Safety, and Tolerability | NCT04159454
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2014) 1.43
The spectrum of epidemiology underlying sudden cardiac death. Circ Res (2015) 1.26
Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry. Arq Bras Cardiol (2016) 0.97
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. J Am Heart Assoc (2015) 0.94
Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease. World J Cardiol (2014) 0.87
Atrial fibrillation in heart failure: what should we do? Eur Heart J (2015) 0.86
Ventricular conduction defects and the risk of incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study. J Card Fail (2015) 0.84
See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther (2013) 0.84
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis. Circulation (2016) 0.83
Sudden Cardiac Death in the Young. Circulation (2016) 0.83
National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator. Circulation (2015) 0.82
Development and validation of a phase analysis tool to measure interventricular mechanical dyssynchrony from gated SPECT MPI. J Nucl Cardiol (2016) 0.81
Endoscopic Electrosurgery in Patients with Cardiac Implantable Electronic Devices. Clin Endosc (2016) 0.81
Assessment of adaptive rate response provided by accelerometer, minute ventilation and dual sensor compared with normal sinus rhythm during exercise: a self-controlled study in chronotropically competent subjects. Chin Med J (Engl) (2015) 0.81
Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid? BMC Cardiovasc Disord (2016) 0.80
Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes. J Am Heart Assoc (2016) 0.80
Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE. Circ Heart Fail (2014) 0.79
The transition to value-based care. J Interv Card Electrophysiol (2016) 0.78
The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations. Arrhythm Electrophysiol Rev (2015) 0.78
Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD). J Behav Med (2015) 0.77
Sites of latest mechanical activation as assessed by SPECT myocardial perfusion imaging in ischemic and dilated cardiomyopathy patients with LBBB. Eur J Nucl Med Mol Imaging (2014) 0.77
Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view. J Cardiovasc Med (Hagerstown) (2016) 0.76
Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience. J Arrhythm (2015) 0.76
Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther (2013) 0.76
Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT. Heart Fail Rev (2015) 0.76
Traumatic Tension Pneumothorax as a Cause of ICD Failure: A Case Report and Review of the Literature. Case Rep Cardiol (2014) 0.75
Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun (2014) 0.75
Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis. J Interv Card Electrophysiol (2014) 0.75
Genotypic and phenotypic predictors of complete heart block and recovery of conduction after surgical repair of congenital heart disease. Heart Rhythm (2016) 0.75
Sudden cardiac death in patients with nonischemic cardiomyopathy. Indian Heart J (2014) 0.75
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada. BMC Neurol (2015) 0.75
Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization Therapy. Am J Cardiol (2016) 0.75
Prevalence and characterization of coronary artery disease in patients with symptomatic bradyarrhythmias requiring pacemaker implantation. Indian Heart J (2016) 0.75
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. Am J Cardiol (2016) 0.75
Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. Am J Cardiol (2015) 0.75
Heart Failure in Children. Heart Views (2016) 0.75
High sensitivity C-reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure. J Geriatr Cardiol (2014) 0.75
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study. BMC Neurol (2017) 0.75
The effectiveness of cardiac resynchronization therapy for patients with New York Heart Association class IV non-ambulatory heart failure. J Arrhythm (2015) 0.75
Long-term outcome in patients receiving permanent pacemaker implantation for atrioventricular block: Comparison of VDD and DDD pacing. Medicine (Baltimore) (2016) 0.75
Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea. Yonsei Med J (2017) 0.75
Late Gadolinium Enhancement Amount As an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart Failure. Front Physiol (2016) 0.75
Arrhythmias in 2016: Arrhythmia treatment - evidence catching up with technology. Nat Rev Cardiol (2017) 0.75
Relevance of guideline-based ICD indications to clinical practice. Indian Heart J (2013) 0.75
A regularly irregular rhythm-what is the diagnosis? Neth Heart J (2016) 0.75
Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys. Clin J Am Soc Nephrol (2015) 0.75
Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry. Circulation (2016) 0.75
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Circ Heart Fail (2016) 0.75
Acute and Chronic Changes and Predictive Value of Tpeak-Tend for Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients. Chin Med J (Engl) (2016) 0.75
Ventricular conduction abnormalities as predictors of long-term survival in acute de novo and decompensated chronic heart failure. ESC Heart Fail (2015) 0.75
Fully digital data processing during cardiovascular implantable electronic device follow-up in a high-volume tertiary center. Eur J Med Res (2017) 0.75
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing. Eur J Heart Fail (2017) 0.75
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 17.52
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Universal definition of myocardial infarction. Circulation (2007) 11.69
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm (2009) 5.17
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91